RadNet (RDNT) Competitors $76.08 -1.83 (-2.35%) Closing price 04:00 PM EasternExtended Trading$76.18 +0.09 (+0.12%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RDNT vs. NTRA, HIMS, GH, BTSG, SHC, OPCH, WGS, HTFL, PRVA, and VCYTShould you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Natera (NTRA), Hims & Hers Health (HIMS), Guardant Health (GH), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Heartflow (HTFL), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. RadNet vs. Its Competitors Natera Hims & Hers Health Guardant Health BrightSpring Health Services Sotera Health Option Care Health GeneDx Heartflow Privia Health Group Veracyte Natera (NASDAQ:NTRA) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation. Which has more volatility & risk, NTRA or RDNT? Natera has a beta of 1.74, indicating that its share price is 74% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Which has preferable valuation and earnings, NTRA or RDNT? RadNet has higher revenue and earnings than Natera. RadNet is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B13.92-$190.43M-$1.91-90.10RadNet$1.83B3.20$2.79M-$0.20-380.40 Is NTRA or RDNT more profitable? RadNet has a net margin of -0.78% compared to Natera's net margin of -12.89%. RadNet's return on equity of 2.41% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-12.89% -22.22% -15.03% RadNet -0.78%2.41%0.82% Do analysts rate NTRA or RDNT? Natera presently has a consensus price target of $192.88, indicating a potential upside of 12.08%. RadNet has a consensus price target of $76.80, indicating a potential upside of 0.95%. Given Natera's stronger consensus rating and higher possible upside, analysts plainly believe Natera is more favorable than RadNet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 1 Sell rating(s) 1 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 2.90RadNet 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.88 Does the media refer more to NTRA or RDNT? In the previous week, Natera had 12 more articles in the media than RadNet. MarketBeat recorded 14 mentions for Natera and 2 mentions for RadNet. RadNet's average media sentiment score of 1.70 beat Natera's score of 0.81 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 9 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do institutionals and insiders believe in NTRA or RDNT? 99.9% of Natera shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 5.6% of Natera shares are owned by company insiders. Comparatively, 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryNatera beats RadNet on 9 of the 17 factors compared between the two stocks. Get RadNet News Delivered to You Automatically Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDNT vs. The Competition Export to ExcelMetricRadNetMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.99B$4.24B$6.11B$10.56BDividend YieldN/A1.26%5.69%4.75%P/E Ratio-380.3829.1585.4827.60Price / Sales3.20249.07621.72242.93Price / Cash22.3728.4137.9261.55Price / Book4.974.7013.136.76Net Income$2.79M$197.51M$3.30B$275.88M7 Day Performance-2.45%0.39%5.29%3.72%1 Month Performance5.68%2.36%9.94%10.22%1 Year Performance12.91%29.42%87.78%35.86% RadNet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDNTRadNet3.1886 of 5 stars$76.08-2.3%$76.80+0.9%+16.4%$5.99B$1.83B-380.3811,021Positive NewsAnalyst ForecastNTRANatera2.814 of 5 stars$170.38+1.8%$192.88+13.2%+31.5%$23.38B$1.96B-89.204,434Analyst ForecastHIMSHims & Hers Health3.511 of 5 stars$54.68+4.1%$38.92-28.8%+197.5%$12.36B$1.48B68.351,637Trending NewsInsider TradeGHGuardant Health3.5573 of 5 stars$63.38+0.9%$65.75+3.7%+197.1%$7.90B$739.02M-18.922,021Analyst ForecastBTSGBrightSpring Health Services2.8955 of 5 stars$28.87+1.8%$29.13+0.9%+94.8%$5.11B$12.57B93.1335,000News CoveragePositive NewsAnalyst ForecastSHCSotera Health2.6521 of 5 stars$16.22+1.7%$17.20+6.0%+4.0%$4.61B$1.10B202.783,000Analyst ForecastOPCHOption Care Health4.8735 of 5 stars$27.33-0.6%$35.11+28.5%-4.5%$4.44B$5.00B21.868,088Positive NewsAnalyst ForecastWGSGeneDx2.2973 of 5 stars$120.19+1.6%$104.13-13.4%+128.9%$3.45B$362.32M2,403.801,200Analyst ForecastHTFLHeartflowN/A$37.28-1.0%$36.60-1.8%N/A$3.11B$148.54M0.00699PRVAPrivia Health Group3.7561 of 5 stars$24.13+0.2%$28.58+18.5%+39.6%$2.96B$1.74B219.381,140Positive NewsAnalyst ForecastVCYTVeracyte3.6938 of 5 stars$36.04+0.1%$40.90+13.5%+2.2%$2.84B$445.76M109.22790News CoverageAnalyst UpgradeInsider Trade Related Companies and Tools Related Companies Natera Alternatives Hims & Hers Health Alternatives Guardant Health Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Option Care Health Alternatives GeneDx Alternatives Heartflow Alternatives Privia Health Group Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDNT) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
